# δ in Dementia Clinical Trials

> **NCT05592678** · NA · RECRUITING · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 200 (estimated)

## Conditions studied

- Alzheimer's Disease (AD)
- Dementia
- Cognitive Decline
- Mild Cognitivie Impairment (MCI)

## Interventions

- **OTHER:** Donepezil

## Key facts

- **NCT ID:** NCT05592678
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-05
- **Primary completion:** 2028-11-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05592678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05592678, "δ in Dementia Clinical Trials". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05592678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*